title: The uphill battle facing antiobesity drugs.
authors.affiliation: 1] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA [2] Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, MD, USA.
authors.forename: M
authors.initials: M
authors.lastname: Daubresse
authors.affiliation: 1] Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA [2] Center for Drug Safety and Effectiveness, Johns Hopkins University, Baltimore, MD, USA [3] Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.
authors.forename: G C
authors.initials: GC
authors.lastname: Alexander
mesh_terms: D019440:Anti-Obesity Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000517:prevention & control; D011159:Population Surveillance; D010818:Practice Patterns, Physicians'; D014481:United States; D014486:United States Food and Drug Administration; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D019440:Anti-Obesity Agents